Why the study?
Although double-kissing crush and double-kissing culotte are recommended 2-stent strategies in true coronary bifurcation lesions, it was unclear which technique provides superior clinical results in nonleft main bifurcations.
Does the DK culotte stenting technique reduce target lesion failure compared to DK crush in patients with nonleft main coronary artery bifurcation lesions?
Does the DK culotte stenting technique reduce target lesion failure compared to DK crush in patients with nonleft main coronary artery bifurcation lesions?
In nonleft main coronary artery bifurcations, the DK culotte technique is associated with lower 1-year target lesion failure rates compared to the DK crush technique.
Answers are grounded in this paper and cite their sources.
May favor DK culotte for lower target lesion failure in nonleft main bifurcations; hypothesis-generating and requires randomized confirmation.
BACKGROUND: Double-kissing (DK) crush and DK culotte are the recommended 2-stent strategies in true coronary bifurcation lesions. However, it is a matter of curiosity about which of the DK crush and DK culotte stenting techniques will have superior results. We aimed to compare the clinical outcomes of DK crush and DK culotte stenting in nonleft main coronary artery bifurcation. METHODS: Consecutive patients who received DK crush or DK culotte technique for de novo true nonleft main coronary artery bifurcation lesion were categorized according to which treatment they received. The primary end point of the study was target lesion failure as a composite end point of target lesion revascularization, target vessel myocardial infarction, and cardiac death. Secondary end points were all-cause death and definite stent thrombosis. There were no differences in terms of definite stent thrombosis and all-cause death between groups. CONCLUSIONS: In the present analysis, DK culotte was associated with lower 1-year target lesion failure rates compared with DK crush in true nonleft main coronary artery bifurcations. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04789161.
No takes yet. Share an insight, caveat, or question.
Kahraman et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: